Loading... Please wait...Connecting to intelligent information in the electronic age.
New PublicationsBIOSENSORS IN MEDICAL DIAGNOSTICS MCP-3310
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability And Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions And Scope Of Study I-3
Medical Biosensors I-4
Glucose Sensors I-4
Other Sensors I-4
Environmental Biosensors I-4
Other Biosensors I-4
II. EXECUTIVE SUMMARY
1. Global Market Overview and Analysis II-1
Commercialization of Biosensors-Challenges Ahead II-1
Facts and General Trends II-1
Regulations Encumber Biosensors Market Growth II-2
Impediments to Commercialization II-2
Global Biosensors Market II-3
Medical Biosensors: A Promising Area II-3
Increasing Medical Applications for Biosensors II-3
Painless Technologies Spark Evolution in Glucose Monitoring
Segment II-3
Biosensors Primarily Used in Blood Gas/Electrolyte
Analyzers, Glucose Meters & Metabolite Analyzers II-4
Swift Growth of Biosensors Demand in Medical Diagnostics II-4
Growing Demand and R&D Activities Drive the Biosensors Market II-4
2. A Retrospective II-5
3. Competitive Scenario II-6
Intensity of Competition II-6
4. Product Overview II-8
About Biosensors II-8
Types of Biosensors II-8
Components of Biosensors II-9
Types of Biosensors II-9
Glucose Sensor II-9
Medical Telesensors II-10
Detecting Cancer and Health Abnormalities II-10
Lactate Sensor II-10
Alcohol Sensor II-11
Biochemical Oxygen Demand Sensor (BOD) II-11
Bioreporters II-11
Miniaturized Devices II-11
Components of Biosensors II-11
Receptor II-11
Transducer II-11
Separator II-11
Biological Components II-12
Attributes of a Good Biosensor II-12
Classes of Biosensors II-12
Potentiometric II-13
Amperometric II-13
Optical Biosensors II-13
Other Physicochemical Biosensors II-13
Methods to Manufacture Optical Biosensors II-13
Simple Fiber Optic Biosensors II-13
Evanescent Wave System II-13
Surface Plasmon Resonance (SPR) II-14
5. Application Areas II-15
A. Medical Applications II-15
Glucose Meters II-15
The Diabetes Monitoring Market II-15
Categorization II-16
Biosensors in Home Glucose Monitors II-16
PBGM Devices: Based on Photometric or Biosensor Technology II-16
Product Innovations Rule the Roost II-17
Non-Invasive Products II-17
Blood Gas Market II-17
Sensors Facilitate Analysis of Blood II-18
Market for DNA Biosensors and Genechips in Nascent Stage II-18
B. Environmental Biosensors II-19
C. Industrial Applications II-20
Summarization of Available Biosensors & Technological
Applications II-20
D. Other Application Areas II-21
Biological Warfare- An Increasingly Important Area for
Biosensors II-21
Fingerprinting- A Much Needed Advantage? II-21
6. Product Launches/Innovations II-22
WaveSense Europe Unveils New Jazz Blood Glucose Meter in UK II-22
Mexico Inventors Develop Integrated Optical Biosensor System II-22
New Biosensor Detects Avian Influenza Virus II-22
US Scientists to Develop Nano-based Biosensor II-22
Japanese Inventors Develop New Biosensor II-22
US Scientists Develops New Biosensor II-22
NeoSensors Re-Introduces Biosensor Product Range II-23
Siemens Medical Releases Rapidlab Version 2.0 Software II-23
Innovative Biosensors Unveils BioFlash Biological Detector II-23
Medtronic Introduces Guardian(R) Real-Time System for Diabetes
Management II-23
Nova Biomedical Introduces Nova Max Blood Glucose Monitor II-24
ARKRAY Introduces PocketChem EZ Blood Glucose Monitoring Device II-24
Medtronic Unveils Continuous Glucose Monitoring System II-24
Abbott Introduces FreeStyle Lite II-24
SPO Medical Launches Two Oximetry Devices II-24
ForteBio Launches New Biosensors for Research and Development II-25
Axela Biosensors Unveils dotLab System II-25
California Inventor Develops Anti Inflammatory Biosensor II-25
Japanese Inventors Develop Measuring System for Biosensor II-25
Biophage Develops New Biosensor II-25
AMBRI Develops New Influenza Biosensor II-26
LifeScan Unveils OneTouch(R) UltraMini Blood Glucose
Monitoring System II-26
Akubio Introduces RAP•d 4 Biomolecular Interactions Analysis
System II-26
Bio-Rad Launches ProteOn XPR36 Protein Interaction Array System II-26
Exmovere Introduces Bluetooth-Enabled Biosensor Wristwatch II-27
SPO Medical Unveils Compact Oximetry System, PulseOx 7500 II-27
Panasonic Introduces Multi-Task Biosensor for Disease Detection II-27
Medtronic Launches Glucose Monitoring System in India II-28
ForteBio Introduces New Biosensors for Octet System II-28
7. Recent Industry Activity II-29
Medtronic Receives FDA Clearance on OneTouch(R) U ltralink II-29
Medtronic Bags FDA Approval on CGMS(R) iPro II-29
T+ Medical Partners LifeScan for Diabetes Management II-29
Aerotel Medical Systems Takes Over Tadiran LifeCare's
Business Operations II-30
Siemens Medical Completes Acquisition of Bayer's Diagnostic
Division II-30
Biosensors to Purchase 50% Stake in JWMS II-30
Siemens Signs Merger Agreement with Dade Behring II-30
Abbott to Divest Core Laboratory Diagnostics Business II-31
Axela and BioCheck Inks License and Supply Agreement II-31
FDA Grants Waiver for Abbott's i-STAT CHEM8+ II-31
Aventir Receives FDA Approval for GlucosePilot II-31
Inscent to Develop New Biosensor to Save Public Health II-32
Wellion(R) Linus Receives TNO Approval II-32
Virogenomics Receives Grant of US$1.9M to Develop BioSensor
Technology II-32
Acacia Acquires Rights to Patent for Pointing Device Technology II-32
NanoSensors Grants Sub-Contract for Prototype Production of
Biosensor II-32
Axela and Toronto University to Develop Patient Bedside
Testing Devices II-32
Attana and Isogen Ink a Distribution Agreement II-33
Biosense Webster Expands Alliance with Stereotaxis II-33
Medtronic Enters into Exclusive Distribution Agreement with
LifeScan II-33
WaveSense to Launch European Subsidiary, WaveSense Europe II-34
MedMira Acquires SensorChem II-34
Siemens Acquires Diagnostic Products Corporation II-34
Farfield Group Acquires Biosensor Operations of Thermo Electron II-35
Kimberly-Clark Acquires Stake in Axela Biosensors II-35
Bionas and Primacyt Co-operates to Develop Cell-Based Assay II-35
Biosensors Japan Co. to Sell Stents in Japan II-35
Isis Receives Copyright for Pathogen Identification Methodology II-35
Micronics Issues Patent License to Cleveland II-36
Medtronic Receives US FDA Approval on New CGM System II-36
AgaMatrix Bags FDA Approval to Market Wave 1 II-36
BRI to Acquire Lumera's Biosensor Instrument II-36
Bruker Daltonics Enters into Strategic Alliance with Isis
Pharmaceuticals II-36
NeuroMetrix Inks Manufacturing Agreement with Parlex USA II-37
Synthetic Blood International Enters into Strategic Alliance
With UTEK II-37
EPSRC Enters Joint Research Agreement with Philips II-37
Biophage Pharma Enters Agreement with Biosensor Systems II-37
Axis Participates in Biosensor Platform Development Project II-37
US Genomics Bags Biosensor Contract from DHS II-38
Bio-Nano Sensium Files Patent Application for Wireless
Biosensors II-38
SPO Medical Completes Reverse Acquisition of United Diagnostic II-38
Biophage Pharma Develops New Technology to Detect Bacteria II-38
Cygnus Turns to Liquidation II-38
TGC Research Acquires Certain Assets of Diametrics II-39
Diametrics Restructures II-39
Abbott Acquires I-Stat II-39
Seahawk Contracts with In-Q-Tel II-39
Pinnacle Signs an Agreement with Primetech II-39
RoboDesign Enters into an Agreement with Isis II-39
Theron Enters into a Licensing Agreement II-40
Innovative Biosensors Enters Licensing Agreement with MIT II-40
Biosensors International and X-Cell Medical Mutually Agree to
Form a New Company II-40
Biosensors International Private Ltd. Divests Stent System to
Guidant Corporation II-40
Medtronic Acquires MiniMed, Inc. and Medical Research Group,
Inc. II-40
Virtek Vision Acquires FONA Diagnostics II-41
Dow Corning Strategically Alliances with Genencor II-41
Synthetic Blood International Obtains Patent II-41
Prolinx Forges an Agreement with Texas Instruments II-42
Kumetrix Bags SBIR Contract from NIDDK II-42
Standard MEMS Forms BioMEMS Technology Group II-42
8. Technological Developments II-43
Holograms - The Next Generation Biosensors .. II-43
Smart Bandages- A New Way of Wound Care II-43
PulseTracer Unveils PT100 Biosensor II-43
Molecular Biology- Increasingly Used in the Biosensor Business II-43
Micro-System Platforms for Biosensor Applications II-44
Microelectromechanical Systems- Creating New Horizons II-44
Biochips: Increasingly Being Used in Point-Of-Care Devices II-44
Implantable Biosensors: A Possibility in the Near Future II-45
Biosensors to Carry Out Medical-Checkups at Home II-45
Immunosensors to Enhance Current Immunoassay Techniques II-45
Microfluidic Glucose Sensor II-45
Biosensors in Mycotoxin Detection II-46
Some Major Technological Developments in Recent Years II-46
Animas into Development of Implantable Sensors for Blood
Glucose II-46
Cytoplex Develops Biosensor II-46
Immunosensor Ricin Detector II-47
Biosensor to Identify Viruses Electronically II-47
Electrochemical Array Biosensor Technology II-47
Polymer-Coated Microheaters Enters Market II-47
Technology Archive II-47
UCSD Instrumental in the Development of Polymer-based,
Nanoscale Biosensors II-47
Applied Digital Solutions Launches VeriChip II-48
Applied Digital Solutions, Inc. Incorporates Biosensors
Technology in New Device II-48
University of Rhode Island Develops Biosensor to Detect
Pathological Bacteria in Foods II-48
Cellomics Launches the Development of Biowarfare Detection II-48
Biosensors- Speed Pathogen Detection II-49
Optic Interferometic Sensor for Detecting Biological Hazards
and Attacks II-49
Digital Signal Processing Technology (DSP) in Biosensors II-50
The World's Smallest Biosensors II-50
MiniMed Gains FDA Approval for Its Subcutaneous Glucose Sensor II-50
The Nanomachine: The World's Smallest Machine II-51
Knoxville Cancer Survival Center Develops Laser-based Sensor II-51
Genetic Engineering Creates Biosensors to Clean Environment II-51
New Horizons Develops Immunoassay Tests II-52
John Hopkins University Develops New Alfa-Toxin Fab II-52
Texas Instruments Develops a New Surface Plasmon Resonance
Sensor II-52
A New Biosensor to Confirm Pregnancy II-52
Gold Biosensor to Detect Carcinogens II-53
Drug Detecting Biosensor II-53
Functional Genomics Technology Uses Biosensors II-53
9. Focus on Select Players II-54
Companies Developing Biosensor-Based Devices II-54
Abbott Point of Care, Inc. (USA) II-54
Affinity Sensors (USA) II-54
Neosensors Limited (UK) II-54
Siemens Healthcare Diagnostics Inc (USA) II-54
Animas Corp (US) II-54
Lifescan, Inc. (USA) II-55
Medtronic Diabetes (USA) II-55
Roche Diagnostics Ltd. (USA) II-55
Leading Developers of Biosensor Technology II-55
AgaMatrix Inc. (USA) II-55
Cranfield Health (UK) II-56
LifeSensors INC. (USA) II-56
M-Biotech (USA) II-56
Nova Biomedical Corp. (USA) II-56
10. Global Market Perspective II-58
Table 1: World Recent Past, Current & Future Market Analysis
for Biosensors by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Rest of World
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-58
Table 2: World Long-term Projections for Biosensors by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-59
Table 3: World 10-Year Perspective for Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-60
Table 4: World Recent Past, Current & Future Market Analysis
for Medical Biosensors by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Rest of
World Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-61
Table 5: World Recent Past, Current & Future Market Analysis
for Medical Biosensors by Product Segments- Glucose Biosensors
and Other Medical Biosensors Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010) (includes corresponding Graph/Chart) II-62
Table 6: World Long-term Projections for Medical Biosensors by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-63
Table 7: World Long-term Projections for Medical Biosensors by
Product Segment - Glucose Biosensors and Other Medical
Biosensors Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-64
Table 8: World 10-Year Perspective for Medical Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-65
Table 9: World 10-Year Perspective for Medical Biosensors by
Product Segment- Percentage Breakdown of Value Sales for
Glucose Biosensors and Other Medical Biosensors Markets for
Years 2003, 2008 & 2012 II-65
Table 10: World Recent Past, Current & Future Market Analysis
for Glucose Biosensors by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Rest of
World Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-66
Table 11: World Long-term Projections for Glucose Biosensors
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-67
Table 12: World 10-Year Perspective for Glucose Biosensor by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-68
Table 13: World Recent Past, Current & Future Market Analysis
for Other Medical Biosensors by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest
of World Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-69
Table 14: World Long-term Projections for Other Medical
Biosensors by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-70
Table 15: World 10-Year Perspective for Other Medical
Biosensor by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Rest of World Markets for Years 2003,
2008 & 2012 (includes corresponding Graph/Chart) II-71
Table 16: World Recent Past, Current & Future Market Analysis
for Environmental Biosensors by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest
of World Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-72
Table 17: World Long-term Projections for Environmental
Biosensors by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-73
Table 18: World 10-Year Perspective for Environmental
Biosensor by Geographic Region - Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Rest of World Markets for Years 2003,
2008 & 2012. (includes corresponding Graph/Chart) II-74
Table 19: World Recent Past, Current & Future Market Analysis
for Other Biosensors by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Rest of World
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-75
Table 20: World Long-term Projections for Other Biosensors by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-76
Table 21: World 10-Year Perspective for Other Biosensor by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-77
III. MARKET
1. The United States III-1
A.Market Analysis III-1
Other Facts and Figures III-1
The US Diabetes Monitoring Market III-1
Biosensors- Speeding Pathogen Detection III-1
Product Launches/Innovations III-2
Strategic Corporate Developments III-9
Focus on Select Key Players III-17
Companies Developing Biosensor-Based Devices III-17
Abbott Point Of Care, Inc. III-17
Affinity Sensors III-17
Animas Corporation III-17
Siemens Healthcare Diagnostics Inc III-17
LifeScan III-18
Medtronic Diabetes III-18
Roche Diagnostics Ltd. III-18
Leading Developers of Biosensor Technology III-18
AgaMatrix Inc. III-18
LifeSensors Inc. III-19
M-Biotech III-19
Nova Biomedical Corp. III-19
B.Market Analytics III-20
Table 22: US Recent Past, Current & Future Market Analysis
for Biosensors by Product Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-20
Table 23: US Long-term Projections for Biosensors by Product
Segment - Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-20
Table 24: US 10-Year Perspective for Biosensors by Product
Segment - Percentage Breakdown of Value Sales for Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-21
2. Canada III-22
A.Market Analysis III-22
Biosensor Researches in Canada III-22
Microfluidic Systems III-22
Biosensor Institutions III-22
Strategic Corporate Developments III-22
Product Launches III-23
B.Market Analytics III-24
Table 25: Canadian Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-24
Table 26: Canadian Long-term Projections for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-25
Table 27: Canadian 10-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-25
3. Japan III-26
A.Market Analysis III-26
Product Launches/Innovations III-26
Strategic Corporate Developments III-27
B.Market Analytics III-28
Table 28: Japanese Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-28
Table 29: Japanese Long-term Projections for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-29
Table 30: Japanese 10-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-29
4. Europe III-30
A.Market Analysis III-30
Market Trends & Issues III-30
Environmental Monitoring Diffusing in the European Countries III-30
B.Market Analytics III-31
Table 31: European Recent Past, Current & Future Market
Analysis for Biosensors by Geographic Region - France,
Germany, Italy, UK & Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) III-31
Table 32: European Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-31
Table 33: European Long-term Projections for Biosensors by
Geographic Region - France, Germany, Italy, UK, and Rest of
Europe Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-32
Table 34: European Long-term Projections for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-32
Table 35: European 10-Year Perspective for Biosensors by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK & Rest of Europe Markets for
Years 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-33
Table 36: European 10-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-33
4a. France III-34
Market Analysis III-34
Table 37: French Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-34
Table 38: French Long-term Projections for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-35
Table 39: French 10-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-35
4b. Germany III-36
A.Market Analysis III-36
Strategic Corporate Developments III-36
B.Market Analytics III-37
Table 40: German Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-37
Table 41: German Long-term Projections for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-38
Table 42: German 10-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-38
4c. Italy III-39
Market Analysis III-39
Table 43: Italian Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment - Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with
Annual Sales Figures
in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-39
Table 44: Italian Long-term Projections for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-40
Table 45: Italian 10-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-40
4d. The United Kingdom III-41
A.Market Analysis III-41
Outlook of Industrial Biosensors III-41
Key Players III-41
Cranfield Health III-41
Neosensors Limited III-41
Product Launches/Innovations III-42
Strategic Corporate Developments III-42
B.Market Analytics III-44
Table 46: UK Recent Past, Current & Future Market Analysis
for Biosensors by Product Segment - Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-44
Table 47: UK Long-term Projections for Biosensors by
Product Segment - Medical Biosensors (Glucose Biosensors
and Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-45
Table 48: UK 10-Year Perspective for Biosensors by Product
Segment - Percentage Breakdown of Value Sales for Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-45
4e. Rest of Europe III-46
A.Market Analysis III-46
Strategic Corporate Developments III-46
B.Market Analytics III-47
Table 49: Rest of Europe Market for Biosensors - Recent
Past, Current & Future Analysis by Product Segment for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-47
Table 50: Rest of Europe Long-term Projections for
Biosensors by Product Segment - Medical Biosensors (Glucose
Biosensors and Other Medical Biosensors), Environmental
Biosensors and Other Biosensors Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-48
Table 51: Rest of Europe 10-Year Perspective for Biosensors
by Product Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-49
5. Asia-Pacific III-50
A.Market Analysis III-50
Strategic Development III-50
Product Launch III-50
Historic Review III-50
CFTRI of India Announces New Biosensor III-50
CRC Develops an Extremely High Sensor III-50
Nanomachine Developed in Australia III-51
B.Market Analytics III-51
Table 52: Asia Pacific Market for Biosensors - Recent
Past, Current & Future Analysis by Product Segment for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-51
Table 53: Asia-Pacific Long-term Projections for Biosensors
by Product Segment - Medical Biosensors (Glucose Biosensors
and Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-52
Table 54: Asia Pacific 10-Year Perspective for Biosensors by
Product Segment - Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-53
6. Rest of World III-54
A.Market Analysis III-54
Strategic Corporate Development III-54
B.Market Analytics III-55
Table 55: Rest of World Market for Biosensors - Recent Past,
Current & Future Analysis by Product Segment for Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-55
Table 56: Rest of World Long-term Projections for Biosensors
by Product Segment - Medical Biosensors (Glucose Biosensors
and Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-56
Table 57: Rest of World 10-Year Perspective for Biosensors
by Product Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-57
IV. COMPETITIVE LANDSCAPE
Choose a currency below to display product prices in the selected currency.